Dolby Laboratories, Inc. (NYSE: DLB) Stock Competitors & Peer Comparison

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, SAP has a market cap of 272.1B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while SAP trades at $233.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas SAP's P/E ratio is 29.44. In terms of profitability, DLB's ROE is +0.09%, compared to SAP's ROE of +0.18%. Regarding short-term risk, DLB is more volatile compared to SAP. This indicates higher risk in terms of short-term price fluctuations for DLB.Check SAP's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, SHOP has a market cap of 191.6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while SHOP trades at $148.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas SHOP's P/E ratio is 94.25. In terms of profitability, DLB's ROE is +0.09%, compared to SHOP's ROE of +0.17%. Regarding short-term risk, DLB is less volatile compared to SHOP. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SHOP's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, CRM has a market cap of 175.9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while CRM trades at $213.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas CRM's P/E ratio is 15.43. In terms of profitability, DLB's ROE is +0.09%, compared to CRM's ROE of +0.20%. Regarding short-term risk, DLB is less volatile compared to CRM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CRM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, UBER has a market cap of 140.1B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while UBER trades at $68.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas UBER's P/E ratio is 14.35. In terms of profitability, DLB's ROE is +0.09%, compared to UBER's ROE of +0.13%. Regarding short-term risk, DLB is more volatile compared to UBER. This indicates higher risk in terms of short-term price fluctuations for DLB.Check UBER's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, ADP has a market cap of 119.7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while ADP trades at $303.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas ADP's P/E ratio is 27.28. In terms of profitability, DLB's ROE is +0.09%, compared to ADP's ROE of +0.76%. Regarding short-term risk, DLB is more volatile compared to ADP. This indicates higher risk in terms of short-term price fluctuations for DLB.Check ADP's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, APP has a market cap of 119.6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while APP trades at $391.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas APP's P/E ratio is 30.07. In terms of profitability, DLB's ROE is +0.09%, compared to APP's ROE of +1.83%. Regarding short-term risk, DLB is less volatile compared to APP. This indicates lower risk in terms of short-term price fluctuations for DLB.Check APP's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, NOW has a market cap of 105.8B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while NOW trades at $101.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas NOW's P/E ratio is 27.76. In terms of profitability, DLB's ROE is +0.09%, compared to NOW's ROE of +0.11%. Regarding short-term risk, DLB is more volatile compared to NOW. This indicates higher risk in terms of short-term price fluctuations for DLB.Check NOW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, SNOW has a market cap of 97.3B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while SNOW trades at $275.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas SNOW's P/E ratio is 195.63. In terms of profitability, DLB's ROE is +0.09%, compared to SNOW's ROE of -0.54%. Regarding short-term risk, DLB is less volatile compared to SNOW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SNOW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, ADBE has a market cap of 93.1B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while ADBE trades at $239.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas ADBE's P/E ratio is 10.48. In terms of profitability, DLB's ROE is +0.09%, compared to ADBE's ROE of +0.63%. Regarding short-term risk, DLB is more volatile compared to ADBE. This indicates higher risk in terms of short-term price fluctuations for DLB.Check ADBE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, INTU has a market cap of 91.3B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while INTU trades at $341.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas INTU's P/E ratio is 14.82. In terms of profitability, DLB's ROE is +0.09%, compared to INTU's ROE of +0.23%. Regarding short-term risk, DLB is less volatile compared to INTU. This indicates lower risk in terms of short-term price fluctuations for DLB.Check INTU's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, CDNS has a market cap of 87.8B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while CDNS trades at $319.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas CDNS's P/E ratio is 42.48. In terms of profitability, DLB's ROE is +0.09%, compared to CDNS's ROE of +0.21%. Regarding short-term risk, DLB is less volatile compared to CDNS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CDNS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, DDOG has a market cap of 64.3B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while DDOG trades at $179.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas DDOG's P/E ratio is 74.92. In terms of profitability, DLB's ROE is +0.09%, compared to DDOG's ROE of +0.06%. Regarding short-term risk, DLB is less volatile compared to DDOG. This indicates lower risk in terms of short-term price fluctuations for DLB.Check DDOG's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, ADSK has a market cap of 54.7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while ADSK trades at $261.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas ADSK's P/E ratio is 23.52. In terms of profitability, DLB's ROE is +0.09%, compared to ADSK's ROE of +0.53%. Regarding short-term risk, DLB is more volatile compared to ADSK. This indicates higher risk in terms of short-term price fluctuations for DLB.Check ADSK's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, MSTR has a market cap of 51.9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while MSTR trades at $128.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas MSTR's P/E ratio is -1.33. In terms of profitability, DLB's ROE is +0.09%, compared to MSTR's ROE of -0.26%. Regarding short-term risk, DLB is less volatile compared to MSTR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check MSTR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, VEEV has a market cap of 49.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while VEEV trades at $303.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas VEEV's P/E ratio is 36.47. In terms of profitability, DLB's ROE is +0.09%, compared to VEEV's ROE of +0.14%. Regarding short-term risk, DLB is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for DLB.Check VEEV's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, ROP has a market cap of 47.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while ROP trades at $476.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas ROP's P/E ratio is 23.39. In terms of profitability, DLB's ROE is +0.09%, compared to ROP's ROE of +0.14%. Regarding short-term risk, DLB is more volatile compared to ROP. This indicates higher risk in terms of short-term price fluctuations for DLB.Check ROP's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, WDAY has a market cap of 46.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while WDAY trades at $192.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas WDAY's P/E ratio is 19.97. In terms of profitability, DLB's ROE is +0.09%, compared to WDAY's ROE of +0.17%. Regarding short-term risk, DLB is less volatile compared to WDAY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check WDAY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, TEAM has a market cap of 38.9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while TEAM trades at $153.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas TEAM's P/E ratio is 30.80. In terms of profitability, DLB's ROE is +0.09%, compared to TEAM's ROE of +0.08%. Regarding short-term risk, DLB is less volatile compared to TEAM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TEAM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, STRC has a market cap of 33B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while STRC trades at $99.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas STRC's P/E ratio is -1.03. In terms of profitability, DLB's ROE is +0.09%, compared to STRC's ROE of -0.26%. Regarding short-term risk, DLB is more volatile compared to STRC. This indicates higher risk in terms of short-term price fluctuations for DLB.Check STRC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, ANSS has a market cap of 32.9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while ANSS trades at $374.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas ANSS's P/E ratio is 55.53. In terms of profitability, DLB's ROE is +0.09%, compared to ANSS's ROE of +0.10%. Regarding short-term risk, DLB is more volatile compared to ANSS. This indicates higher risk in terms of short-term price fluctuations for DLB.Check ANSS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, NBIS has a market cap of 31.1B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while NBIS trades at $129.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas NBIS's P/E ratio is -65.05. In terms of profitability, DLB's ROE is +0.09%, compared to NBIS's ROE of +0.01%. Regarding short-term risk, DLB is less volatile compared to NBIS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NBIS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, STRF has a market cap of 30.7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while STRF trades at $103.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas STRF's P/E ratio is -1.06. In terms of profitability, DLB's ROE is +0.09%, compared to STRF's ROE of -0.26%. Regarding short-term risk, DLB is more volatile compared to STRF. This indicates higher risk in terms of short-term price fluctuations for DLB.Check STRF's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, BSP has a market cap of 27B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while BSP trades at $42.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas BSP's P/E ratio is 98.74. In terms of profitability, DLB's ROE is +0.09%, compared to BSP's ROE of +0.18%. Regarding short-term risk, DLB is less volatile compared to BSP. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BSP's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, ZM has a market cap of 26.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while ZM trades at $89.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas ZM's P/E ratio is 14.88. In terms of profitability, DLB's ROE is +0.09%, compared to ZM's ROE of +0.32%. Regarding short-term risk, DLB is more volatile compared to ZM. This indicates higher risk in terms of short-term price fluctuations for DLB.Check ZM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, U has a market cap of 22.7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while U trades at $51.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas U's P/E ratio is -97.15. In terms of profitability, DLB's ROE is +0.09%, compared to U's ROE of -0.11%. Regarding short-term risk, DLB is less volatile compared to U. This indicates lower risk in terms of short-term price fluctuations for DLB.Check U's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, PTC has a market cap of 21.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while PTC trades at $195.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas PTC's P/E ratio is 20.06. In terms of profitability, DLB's ROE is +0.09%, compared to PTC's ROE of +0.28%. Regarding short-term risk, DLB is more volatile compared to PTC. This indicates higher risk in terms of short-term price fluctuations for DLB.Check PTC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, STRK has a market cap of 20.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while STRK trades at $67.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas STRK's P/E ratio is -0.70. In terms of profitability, DLB's ROE is +0.09%, compared to STRK's ROE of -0.26%. Regarding short-term risk, DLB is more volatile compared to STRK. This indicates higher risk in terms of short-term price fluctuations for DLB.Check STRK's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, SSNC has a market cap of 18.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while SSNC trades at $77.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas SSNC's P/E ratio is 12.14. In terms of profitability, DLB's ROE is +0.09%, compared to SSNC's ROE of +0.13%. Regarding short-term risk, DLB is more volatile compared to SSNC. This indicates higher risk in terms of short-term price fluctuations for DLB.Check SSNC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, AZPN has a market cap of 16.7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while AZPN trades at $264.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas AZPN's P/E ratio is 2403.00. In terms of profitability, DLB's ROE is +0.09%, compared to AZPN's ROE of -0.00%. Regarding short-term risk, DLB is more volatile compared to AZPN. This indicates higher risk in terms of short-term price fluctuations for DLB.Check AZPN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, TYL has a market cap of 16.7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while TYL trades at $420.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas TYL's P/E ratio is 36.24. In terms of profitability, DLB's ROE is +0.09%, compared to TYL's ROE of +0.10%. Regarding short-term risk, DLB is more volatile compared to TYL. This indicates higher risk in terms of short-term price fluctuations for DLB.Check TYL's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, FICO has a market cap of 15.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while FICO trades at $704.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas FICO's P/E ratio is 17.73. In terms of profitability, DLB's ROE is +0.09%, compared to FICO's ROE of -0.28%. Regarding short-term risk, DLB is less volatile compared to FICO. This indicates lower risk in terms of short-term price fluctuations for DLB.Check FICO's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, MANH has a market cap of 14.7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while MANH trades at $252.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas MANH's P/E ratio is 49.38. In terms of profitability, DLB's ROE is +0.09%, compared to MANH's ROE of +0.97%. Regarding short-term risk, DLB is more volatile compared to MANH. This indicates higher risk in terms of short-term price fluctuations for DLB.Check MANH's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, DOCU has a market cap of 14.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while DOCU trades at $77.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas DOCU's P/E ratio is 19.26. In terms of profitability, DLB's ROE is +0.09%, compared to DOCU's ROE of +0.18%. Regarding short-term risk, DLB is less volatile compared to DOCU. This indicates lower risk in terms of short-term price fluctuations for DLB.Check DOCU's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, GRAB has a market cap of 13.6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while GRAB trades at $3.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas GRAB's P/E ratio is 24.75. In terms of profitability, DLB's ROE is +0.09%, compared to GRAB's ROE of +0.09%. Regarding short-term risk, DLB is less volatile compared to GRAB. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GRAB's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, GWRE has a market cap of 13.3B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while GWRE trades at $161.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas GWRE's P/E ratio is 46.27. In terms of profitability, DLB's ROE is +0.09%, compared to GWRE's ROE of +0.10%. Regarding short-term risk, DLB is less volatile compared to GWRE. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GWRE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, BSY has a market cap of 13B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while BSY trades at $44.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas BSY's P/E ratio is 35.15. In terms of profitability, DLB's ROE is +0.09%, compared to BSY's ROE of +0.26%. Regarding short-term risk, DLB is less volatile compared to BSY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BSY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, DT has a market cap of 12.6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while DT trades at $43.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas DT's P/E ratio is 24.54. In terms of profitability, DLB's ROE is +0.09%, compared to DT's ROE of +0.06%. Regarding short-term risk, DLB is less volatile compared to DT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check DT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, FROG has a market cap of 12.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while FROG trades at $100.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas FROG's P/E ratio is 103.04. In terms of profitability, DLB's ROE is +0.09%, compared to FROG's ROE of -0.02%. Regarding short-term risk, DLB is less volatile compared to FROG. This indicates lower risk in terms of short-term price fluctuations for DLB.Check FROG's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, BKI has a market cap of 11.9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while BKI trades at $75.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas BKI's P/E ratio is 47.96. In terms of profitability, DLB's ROE is +0.09%, compared to BKI's ROE of +0.06%. Regarding short-term risk, DLB is more volatile compared to BKI. This indicates higher risk in terms of short-term price fluctuations for DLB.Check BKI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, CHYM has a market cap of 11.9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while CHYM trades at $31.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas CHYM's P/E ratio is -447.29. In terms of profitability, DLB's ROE is +0.09%, compared to CHYM's ROE of +0.06%. Regarding short-term risk, DLB is less volatile compared to CHYM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CHYM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, PCOR has a market cap of 11.4B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while PCOR trades at $75.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas PCOR's P/E ratio is 50.89. In terms of profitability, DLB's ROE is +0.09%, compared to PCOR's ROE of -0.03%. Regarding short-term risk, DLB is less volatile compared to PCOR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check PCOR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, DAY has a market cap of 11.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while DAY trades at $69.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas DAY's P/E ratio is -73.54. In terms of profitability, DLB's ROE is +0.09%, compared to DAY's ROE of -0.07%. Regarding short-term risk, DLB is more volatile compared to DAY. This indicates higher risk in terms of short-term price fluctuations for DLB.Check DAY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, XM has a market cap of 11B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while XM trades at $18.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas XM's P/E ratio is -10.43. In terms of profitability, DLB's ROE is +0.09%, compared to XM's ROE of -0.52%. Regarding short-term risk, DLB is more volatile compared to XM. This indicates higher risk in terms of short-term price fluctuations for DLB.Check XM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, CDAY has a market cap of 10.9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while CDAY trades at $69.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas CDAY's P/E ratio is 2317.33. In terms of profitability, DLB's ROE is +0.09%, compared to CDAY's ROE of -0.07%. Regarding short-term risk, DLB is more volatile compared to CDAY. This indicates higher risk in terms of short-term price fluctuations for DLB.Check CDAY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, PAYC has a market cap of 10.7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while PAYC trades at $237.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas PAYC's P/E ratio is 22.99. In terms of profitability, DLB's ROE is +0.09%, compared to PAYC's ROE of +0.53%. Regarding short-term risk, DLB is less volatile compared to PAYC. This indicates lower risk in terms of short-term price fluctuations for DLB.Check PAYC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, GRABW has a market cap of 10.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while GRABW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas GRABW's P/E ratio is 0.06. In terms of profitability, DLB's ROE is +0.09%, compared to GRABW's ROE of +0.09%. Regarding short-term risk, DLB is less volatile compared to GRABW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GRABW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, HUBS has a market cap of 10B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while HUBS trades at $200.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas HUBS's P/E ratio is 17.09. In terms of profitability, DLB's ROE is +0.09%, compared to HUBS's ROE of +0.12%. Regarding short-term risk, DLB is less volatile compared to HUBS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check HUBS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, YMM has a market cap of 9.6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while YMM trades at $9.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas YMM's P/E ratio is 14.76. In terms of profitability, DLB's ROE is +0.09%, compared to YMM's ROE of +0.11%. Regarding short-term risk, DLB is more volatile compared to YMM. This indicates higher risk in terms of short-term price fluctuations for DLB.Check YMM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, FIG has a market cap of 9.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while FIG trades at $18.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas FIG's P/E ratio is 52.26. In terms of profitability, DLB's ROE is +0.09%, compared to FIG's ROE of -0.38%. Regarding short-term risk, DLB is less volatile compared to FIG. This indicates lower risk in terms of short-term price fluctuations for DLB.Check FIG's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, ESTC has a market cap of 9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while ESTC trades at $86.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas ESTC's P/E ratio is 33.36. In terms of profitability, DLB's ROE is +0.09%, compared to ESTC's ROE of +0.35%. Regarding short-term risk, DLB is less volatile compared to ESTC. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ESTC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, PCTY has a market cap of 9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while PCTY trades at $173.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas PCTY's P/E ratio is 20.79. In terms of profitability, DLB's ROE is +0.09%, compared to PCTY's ROE of +0.24%. Regarding short-term risk, DLB is less volatile compared to PCTY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check PCTY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, OCFT has a market cap of 8.6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while OCFT trades at $7.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas OCFT's P/E ratio is -3.01. In terms of profitability, DLB's ROE is +0.09%, compared to OCFT's ROE of -0.17%. Regarding short-term risk, DLB is more volatile compared to OCFT. This indicates higher risk in terms of short-term price fluctuations for DLB.Check OCFT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, APPF has a market cap of 8.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while APPF trades at $230.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas APPF's P/E ratio is 40.54. In terms of profitability, DLB's ROE is +0.09%, compared to APPF's ROE of +0.32%. Regarding short-term risk, DLB is less volatile compared to APPF. This indicates lower risk in terms of short-term price fluctuations for DLB.Check APPF's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, DSGX has a market cap of 8B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while DSGX trades at $93.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas DSGX's P/E ratio is 43.89. In terms of profitability, DLB's ROE is +0.09%, compared to DSGX's ROE of +0.12%. Regarding short-term risk, DLB is more volatile compared to DSGX. This indicates higher risk in terms of short-term price fluctuations for DLB.Check DSGX's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, GTLB has a market cap of 8B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while GTLB trades at $48.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas GTLB's P/E ratio is 47.15. In terms of profitability, DLB's ROE is +0.09%, compared to GTLB's ROE of -0.06%. Regarding short-term risk, DLB is less volatile compared to GTLB. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GTLB's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, NATI has a market cap of 8B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while NATI trades at $59.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas NATI's P/E ratio is 44.44. In terms of profitability, DLB's ROE is +0.09%, compared to NATI's ROE of +0.12%. Regarding short-term risk, DLB is more volatile compared to NATI. This indicates higher risk in terms of short-term price fluctuations for DLB.Check NATI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, SMAR has a market cap of 7.9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while SMAR trades at $56.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas SMAR's P/E ratio is -806.71. In terms of profitability, DLB's ROE is +0.09%, compared to SMAR's ROE of -0.19%. Regarding short-term risk, DLB is more volatile compared to SMAR. This indicates higher risk in terms of short-term price fluctuations for DLB.Check SMAR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, TTAN has a market cap of 7.9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while TTAN trades at $81.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas TTAN's P/E ratio is 67.55. In terms of profitability, DLB's ROE is +0.09%, compared to TTAN's ROE of -0.08%. Regarding short-term risk, DLB is less volatile compared to TTAN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TTAN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, ZETA has a market cap of 7.8B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while ZETA trades at $31.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas ZETA's P/E ratio is 36.49. In terms of profitability, DLB's ROE is +0.09%, compared to ZETA's ROE of -0.00%. Regarding short-term risk, DLB is less volatile compared to ZETA. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ZETA's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, AUR has a market cap of 7.6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while AUR trades at $4.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas AUR's P/E ratio is -9.18. In terms of profitability, DLB's ROE is +0.09%, compared to AUR's ROE of -0.48%. Regarding short-term risk, DLB is less volatile compared to AUR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check AUR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, DUOL has a market cap of 7.6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while DUOL trades at $160.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas DUOL's P/E ratio is 18.99. In terms of profitability, DLB's ROE is +0.09%, compared to DUOL's ROE of +0.10%. Regarding short-term risk, DLB is less volatile compared to DUOL. This indicates lower risk in terms of short-term price fluctuations for DLB.Check DUOL's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, IDCC has a market cap of 7.3B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while IDCC trades at $285.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas IDCC's P/E ratio is 25.00. In terms of profitability, DLB's ROE is +0.09%, compared to IDCC's ROE of +0.27%. Regarding short-term risk, DLB is more volatile compared to IDCC. This indicates higher risk in terms of short-term price fluctuations for DLB.Check IDCC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, CWAN has a market cap of 7.3B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while CWAN trades at $24.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas CWAN's P/E ratio is 43.09. In terms of profitability, DLB's ROE is +0.09%, compared to CWAN's ROE of -0.02%. Regarding short-term risk, DLB is more volatile compared to CWAN. This indicates higher risk in terms of short-term price fluctuations for DLB.Check CWAN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, AUROW has a market cap of 7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while AUROW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas AUROW's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to AUROW's ROE of -0.48%. Regarding short-term risk, DLB is less volatile compared to AUROW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check AUROW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, CVLT has a market cap of 6.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while CVLT trades at $158.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas CVLT's P/E ratio is 36.24. In terms of profitability, DLB's ROE is +0.09%, compared to CVLT's ROE of +1.15%. Regarding short-term risk, DLB is less volatile compared to CVLT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CVLT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, LYFT has a market cap of 6.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while LYFT trades at $17.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas LYFT's P/E ratio is 28.43. In terms of profitability, DLB's ROE is +0.09%, compared to LYFT's ROE of +0.91%. Regarding short-term risk, DLB is less volatile compared to LYFT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check LYFT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, NAVN has a market cap of 6.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while NAVN trades at $25.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas NAVN's P/E ratio is 391.92. In terms of profitability, DLB's ROE is +0.09%, compared to NAVN's ROE of -0.28%. Regarding short-term risk, DLB is less volatile compared to NAVN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NAVN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, KVYO has a market cap of 6.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while KVYO trades at $20.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas KVYO's P/E ratio is 26.55. In terms of profitability, DLB's ROE is +0.09%, compared to KVYO's ROE of +0.01%. Regarding short-term risk, DLB is less volatile compared to KVYO. This indicates lower risk in terms of short-term price fluctuations for DLB.Check KVYO's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, COUP has a market cap of 6.1B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while COUP trades at $80.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas COUP's P/E ratio is -17.99. In terms of profitability, DLB's ROE is +0.09%, compared to COUP's ROE of -0.38%. Regarding short-term risk, DLB is more volatile compared to COUP. This indicates higher risk in terms of short-term price fluctuations for DLB.Check COUP's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, OTEX has a market cap of 6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while OTEX trades at $24.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas OTEX's P/E ratio is 5.63. In terms of profitability, DLB's ROE is +0.09%, compared to OTEX's ROE of +0.28%. Regarding short-term risk, DLB is more volatile compared to OTEX. This indicates higher risk in terms of short-term price fluctuations for DLB.Check OTEX's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, NIQ has a market cap of 6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while NIQ trades at $20.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas NIQ's P/E ratio is 56.72. In terms of profitability, DLB's ROE is +0.09%, compared to NIQ's ROE of -0.47%. Regarding short-term risk, DLB is less volatile compared to NIQ. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NIQ's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, NICE has a market cap of 5.9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while NICE trades at $96.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas NICE's P/E ratio is 8.18. In terms of profitability, DLB's ROE is +0.09%, compared to NICE's ROE of +0.10%. Regarding short-term risk, DLB is less volatile compared to NICE. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NICE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, YOU has a market cap of 5.7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while YOU trades at $55.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas YOU's P/E ratio is 37.94. In terms of profitability, DLB's ROE is +0.09%, compared to YOU's ROE of +1.00%. Regarding short-term risk, DLB is less volatile compared to YOU. This indicates lower risk in terms of short-term price fluctuations for DLB.Check YOU's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, OCTV has a market cap of 5.6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while OCTV trades at $20.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas OCTV's P/E ratio is 18.14. In terms of profitability, DLB's ROE is +0.09%, compared to OCTV's ROE of -0.27%. Regarding short-term risk, DLB is more volatile compared to OCTV. This indicates higher risk in terms of short-term price fluctuations for DLB.Check OCTV's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, RNG has a market cap of 5.4B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while RNG trades at $72.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas RNG's P/E ratio is 15.76. In terms of profitability, DLB's ROE is +0.09%, compared to RNG's ROE of -1.63%. Regarding short-term risk, DLB is less volatile compared to RNG. This indicates lower risk in terms of short-term price fluctuations for DLB.Check RNG's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, PEGA has a market cap of 5.3B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while PEGA trades at $32.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas PEGA's P/E ratio is 18.00. In terms of profitability, DLB's ROE is +0.09%, compared to PEGA's ROE of +0.45%. Regarding short-term risk, DLB is less volatile compared to PEGA. This indicates lower risk in terms of short-term price fluctuations for DLB.Check PEGA's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, BRZE has a market cap of 5.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while BRZE trades at $45.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas BRZE's P/E ratio is 111.63. In terms of profitability, DLB's ROE is +0.09%, compared to BRZE's ROE of -0.19%. Regarding short-term risk, DLB is more volatile compared to BRZE. This indicates higher risk in terms of short-term price fluctuations for DLB.Check BRZE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, QTWO has a market cap of 4.6B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while QTWO trades at $73.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas QTWO's P/E ratio is 32.00. In terms of profitability, DLB's ROE is +0.09%, compared to QTWO's ROE of +0.17%. Regarding short-term risk, DLB is less volatile compared to QTWO. This indicates lower risk in terms of short-term price fluctuations for DLB.Check QTWO's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, CCC has a market cap of 4.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while CCC trades at $7.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas CCC's P/E ratio is 19.68. In terms of profitability, DLB's ROE is +0.09%, compared to CCC's ROE of +0.04%. Regarding short-term risk, DLB is more volatile compared to CCC. This indicates higher risk in terms of short-term price fluctuations for DLB.Check CCC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, BILL has a market cap of 4.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while BILL trades at $52.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas BILL's P/E ratio is 21.31. In terms of profitability, DLB's ROE is +0.09%, compared to BILL's ROE of +0.01%. Regarding short-term risk, DLB is less volatile compared to BILL. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BILL's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, GRND-WT has a market cap of 4.4B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while GRND-WT trades at $6.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas GRND-WT's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to GRND-WT's ROE of +3.57%. Regarding short-term risk, DLB is more volatile compared to GRND-WT. This indicates higher risk in terms of short-term price fluctuations for DLB.Check GRND-WT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, CVT has a market cap of 4.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while CVT trades at $8.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas CVT's P/E ratio is -40.57. In terms of profitability, DLB's ROE is +0.09%, compared to CVT's ROE of -0.06%. Regarding short-term risk, DLB is more volatile compared to CVT. This indicates higher risk in terms of short-term price fluctuations for DLB.Check CVT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, PYCR has a market cap of 4.1B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while PYCR trades at $22.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas PYCR's P/E ratio is -187.42. In terms of profitability, DLB's ROE is +0.09%, compared to PYCR's ROE of -0.05%. Regarding short-term risk, DLB is more volatile compared to PYCR. This indicates higher risk in terms of short-term price fluctuations for DLB.Check PYCR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, SRAD has a market cap of 4B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while SRAD trades at $13.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas SRAD's P/E ratio is 225.67. In terms of profitability, DLB's ROE is +0.09%, compared to SRAD's ROE of +0.03%. Regarding short-term risk, DLB is less volatile compared to SRAD. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SRAD's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, LIF has a market cap of 3.9B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while LIF trades at $47.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas LIF's P/E ratio is 23.14. In terms of profitability, DLB's ROE is +0.09%, compared to LIF's ROE of +0.27%. Regarding short-term risk, DLB is less volatile compared to LIF. This indicates lower risk in terms of short-term price fluctuations for DLB.Check LIF's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, PWSC has a market cap of 3.8B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while PWSC trades at $22.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas PWSC's P/E ratio is -67.09. In terms of profitability, DLB's ROE is +0.09%, compared to PWSC's ROE of -0.02%. Regarding short-term risk, DLB is more volatile compared to PWSC. This indicates higher risk in terms of short-term price fluctuations for DLB.Check PWSC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, MNDY has a market cap of 3.7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while MNDY trades at $87.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas MNDY's P/E ratio is 19.75. In terms of profitability, DLB's ROE is +0.09%, compared to MNDY's ROE of +0.12%. Regarding short-term risk, DLB is less volatile compared to MNDY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check MNDY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, WK has a market cap of 3.7B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while WK trades at $72.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas WK's P/E ratio is 25.34. In terms of profitability, DLB's ROE is +0.09%, compared to WK's ROE of -1.57%. Regarding short-term risk, DLB is less volatile compared to WK. This indicates lower risk in terms of short-term price fluctuations for DLB.Check WK's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, AYX has a market cap of 3.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while AYX trades at $48.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas AYX's P/E ratio is -19.15. In terms of profitability, DLB's ROE is +0.09%, compared to AYX's ROE of -0.98%. Regarding short-term risk, DLB is more volatile compared to AYX. This indicates higher risk in terms of short-term price fluctuations for DLB.Check AYX's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, DAVEW has a market cap of 3.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while DAVEW trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas DAVEW's P/E ratio is 0.01. In terms of profitability, DLB's ROE is +0.09%, compared to DAVEW's ROE of +0.75%. Regarding short-term risk, DLB is less volatile compared to DAVEW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check DAVEW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, ENV has a market cap of 3.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while ENV trades at $63.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas ENV's P/E ratio is -13.21. In terms of profitability, DLB's ROE is +0.09%, compared to ENV's ROE of -0.36%. Regarding short-term risk, DLB is more volatile compared to ENV. This indicates higher risk in terms of short-term price fluctuations for DLB.Check ENV's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, NATL has a market cap of 3.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while NATL trades at $47.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas NATL's P/E ratio is 10.00. In terms of profitability, DLB's ROE is +0.09%, compared to NATL's ROE of +0.58%. Regarding short-term risk, DLB is more volatile compared to NATL. This indicates higher risk in terms of short-term price fluctuations for DLB.Check NATL's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, PSFE-WT has a market cap of 3.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while PSFE-WT trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas PSFE-WT's P/E ratio is -0.13. In terms of profitability, DLB's ROE is +0.09%, compared to PSFE-WT's ROE of -0.33%. Regarding short-term risk, DLB is less volatile compared to PSFE-WT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check PSFE-WT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, INST has a market cap of 3.5B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while INST trades at $23.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas INST's P/E ratio is -63.78. In terms of profitability, DLB's ROE is +0.09%, compared to INST's ROE of -0.03%. Regarding short-term risk, DLB is more volatile compared to INST. This indicates higher risk in terms of short-term price fluctuations for DLB.Check INST's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, AGYS has a market cap of 3.4B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while AGYS trades at $121.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas AGYS's P/E ratio is 68.04. In terms of profitability, DLB's ROE is +0.09%, compared to AGYS's ROE of +0.13%. Regarding short-term risk, DLB is less volatile compared to AGYS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check AGYS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, ZI has a market cap of 3.4B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while ZI trades at $9.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas ZI's P/E ratio is 77.92. In terms of profitability, DLB's ROE is +0.09%, compared to ZI's ROE of -0.50%. Regarding short-term risk, DLB is more volatile compared to ZI. This indicates higher risk in terms of short-term price fluctuations for DLB.Check ZI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, INTA has a market cap of 3.3B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while INTA trades at $43.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas INTA's P/E ratio is 34.41. In terms of profitability, DLB's ROE is +0.09%, compared to INTA's ROE of -0.08%. Regarding short-term risk, DLB is less volatile compared to INTA. This indicates lower risk in terms of short-term price fluctuations for DLB.Check INTA's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, BLSH has a market cap of 3.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while BLSH trades at $21.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas BLSH's P/E ratio is 56.77. In terms of profitability, DLB's ROE is +0.09%, compared to BLSH's ROE of -0.45%. Regarding short-term risk, DLB is less volatile compared to BLSH. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BLSH's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6.1B. In comparison, ALRM has a market cap of 3.2B. Regarding current trading prices, DLB is priced at $64.83 on the NYSE, while ALRM trades at $65.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 15.44, whereas ALRM's P/E ratio is 23.85. In terms of profitability, DLB's ROE is +0.09%, compared to ALRM's ROE of +0.14%. Regarding short-term risk, DLB is less volatile compared to ALRM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ALRM's competition here